BCMA-directed CAR-T cell therapy

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BCMA-directed CAR-T cell therapy, covering 2026-02-11 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma [Phase 1]